Analysts' ratings for Allstate ALL over the last quarter vary from bullish to bearish, as provided by 13 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 6 | 1 | 2 | 0 |
| Last 30D | 0 | 0 | 0 | 1 | 0 |
| 1M Ago | 0 | 3 | 1 | 1 | 0 |
| 2M Ago | 3 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $182.15, a high estimate of $200.00, and a low estimate of $146.00. Witnessing a positive shift, the current average has risen by 7.41% from the previous average price target of $169.58.
Decoding Analyst Ratings: A Detailed Look
In examining recent analyst actions, we gain insights into how financial experts perceive Allstate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Elyse Greenspan | Wells Fargo | Raises | Underweight | $153.00 | $146.00 |
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $193.00 | $185.00 |
| Michael Phillips | Morgan Stanley | Raises | Overweight | $190.00 | $187.00 |
| Elyse Greenspan | Wells Fargo | Raises | Underweight | $146.00 | $145.00 |
| Oliver Wintermantel | Evercore ISI Group | Raises | In-Line | $173.00 | $166.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $189.00 | $181.00 |
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $185.00 | $172.00 |
| Harry Fong | Roth MKM | Raises | Buy | $200.00 | $175.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $188.00 | $172.00 |
| Vikram Gandhi | HSBC | Announces | Buy | $190.00 | - |
| Alex Scott | Goldman Sachs | Raises | Buy | $195.00 | $164.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $181.00 | $171.00 |
| Brian Meredith | UBS | Raises | Buy | $185.00 | $171.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Allstate. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Allstate compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
To gain a panoramic view of Allstate's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Allstate analyst ratings.
Unveiling the Story Behind Allstate
Allstate is one of the largest US property and casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 company agencies.
Key Indicators: Allstate's Financial Health
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Allstate displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 8.68%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Allstate's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 9.84%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Allstate's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.3% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.43%, the company showcases effective utilization of assets.
Debt Management: Allstate's debt-to-equity ratio surpasses industry norms, standing at 0.5. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
The Core of Analyst Ratings: What Every Investor Should Know
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
